
BPC-157 / TB-500 Blend

For in vitro research only
A 10 mg blend of BPC-157 and TB-500 supplied as a lyophilized vial for research into synergistic tissue repair and recovery.
Size
Quantity
Promotion
Everything you need to start is included.
New
Technical specification
Key attributes
Each vial is intended for laboratory use only.
Research usage
BPC-157 and TB-500 (Thymosin Beta-4) are peptides studied for tissue repair through distinct but complementary mechanisms. BPC-157, a stable gastric pentadecapeptide, promotes angiogenesis and growth-factor regulation, while TB-500, a fragment of Thymosin Beta-4, supports cell migration, tissue regeneration, and reduced inflammation. Combined, they are investigated for synergistic effects on recovery.
The synergy is attributed to overlapping yet distinct pathways: BPC-157 improves blood flow and reduces inflammation while TB-500 facilitates cellular migration to the injury site. Early animal studies suggest the combination may shorten recovery times and improve the structural integrity of repaired tissues, though much of the evidence remains preclinical.
Both peptides have shown favorable tolerability in animal research. Human clinical safety data are limited, and as a blend its combined profile remains largely preclinical and not fully characterized.

BPC-157 / TB-500 Blend
Research journal
BPC-157 and TB-500 are frequently studied together; a blend supplies both peptides in a single lyophilised vial for repair-related research.
A synthetic pentadecapeptide derived from a protective protein in human gastric juice, studied for tissue repair, gut protection, and systemic healing.
A synthetic fragment of Thymosin beta-4, studied for actin regulation, tissue regeneration, and complementary use with BPC-157 in repair protocols.